At the 2022 Bioprocessing Summit, Demeetra’s Corey Brizzee presented Cas-CLOVER’s mechanism and newly engineered variants. This proven platform is enabling gene editing with extremely high efficiency and very low cell toxicity.

View the presentation below.

Learn more about Cas-CLOVER

Read our Peer-reviewed Publications

Build production-ready CHO cell lines with Demeetra

Talk to our team about CHO cell line development, or explore licensing and product access – including Super piggyBac.

Talk to an Expert
Explore Licensing Options